Phase 1 Parkinson's Disease Trial, Recruiting (NCT07557706)

Phase 1 Parkinson's Disease Trial, Recruiting NCT07557706 Sponsor: University of Alabama at Birmingham Condition: Parkinson's Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07557706 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Parkinsons Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease that does not have a known cause (called "idiopathic" Parkinson's disease)
Your Parkinson's medication has not changed for at least 4 weeks before the study begins

Who may not be able to join:

You currently take beta-blocker medications (a type of medicine often used for heart conditions or high blood pressure)
You have consistently very high blood pressure (180/110 mmHg or above when measured sitting down)
You have a serious heart rhythm problem that is not well controlled
You have unstable angina (chest pain caused by reduced blood flow to the heart that is not well managed)
You have congestive heart failure (a condition where the heart does not pump blood as well as it should)
You have previously had a heart attack
You have a history of seizures
You have severe problems with memory, thinking, or understanding
You are pregnant or planning to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

Phase 1: approximately ~10% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 205-975-5221

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07557706

Sponsor: University of Alabama at Birmingham

Phase: Phase 1

Status: Recruiting

Condition: Parkinson's Disease

Trial contact: 205-975-5221

More information: https://clinicaltrials.gov/study/NCT07557706

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Parkinson's disease that does not have a known cause (called "idiopathic" Parkinson's disease)
Your Parkinson's medication has not changed for at least 4 weeks before the study begins

Who may not be able to join:

You currently take beta-blocker medications (a type of medicine often used for heart conditions or high blood pressure)
You have consistently very high blood pressure (180/110 mmHg or above when measured sitting down)
You have a serious heart rhythm problem that is not well controlled
You have unstable angina (chest pain caused by reduced blood flow to the heart that is not well managed)
You have congestive heart failure (a condition where the heart does not pump blood as well as it should)
You have previously had a heart attack
You have a history of seizures
You have severe problems with memory, thinking, or understanding
You are pregnant or planning to become pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 1

Sponsor

University of Alabama at Birmingham

Registry

ClinicalTrials.gov

Start date

15 September 2025

Est. completion

31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in heart rate; Change in blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov